These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 309446)

  • 41. [Plasma and tissues distribution of misonidazole (RO 07-0582) in the rat bearing a chimio induced tumor (author's transl)].
    Akel G; Canal P; Bugat R; Soula G; Combes PF
    J Pharmacol; 1981; 12(4):383-91. PubMed ID: 7321570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pharmacokinetics of misonidazole in the dog.
    White RA; Workman P; Freedman LS; Owen LN; Bleehen NM
    Eur J Cancer (1965); 1979 Oct; 15(10):1233-42. PubMed ID: 520395
    [No Abstract]   [Full Text] [Related]  

  • 43. Biochemistry of reduction of nitro heterocycles.
    Biaglow JE; Varnes ME; Roizen-Towle L; Clark EP; Epp ER; Astor MB; Hall EJ
    Biochem Pharmacol; 1986 Jan; 35(1):77-90. PubMed ID: 2934068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole.
    Varghese AJ; Whitmore GF
    Cancer Res; 1980 Jul; 40(7):2165-9. PubMed ID: 6155991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic considerations of misonidazole in therapeutics.
    Matheson I; Plowman PN; Johnston A
    Hum Toxicol; 1984 Feb; 3(1):29-36. PubMed ID: 6698564
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The radiation reduction in misonidazole.
    Whillans DW; Whitmore GF
    Radiat Res; 1981 May; 86(2):311-24. PubMed ID: 7232695
    [No Abstract]   [Full Text] [Related]  

  • 47. Reduction of 2-, 4- and 5-nitroimidazole drugs by hydrogenase 1 in Clostridium pasteurianum.
    Church DL; Rabin HR; Laishley EJ
    J Antimicrob Chemother; 1990 Jan; 25(1):15-23. PubMed ID: 2180890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analogues of RSU-1069: radiosensitization and toxicity in vitro and in vivo.
    Ahmed I; Jenkins TC; Walling JM; Stratford IJ; Sheldon PW; Adams GE; Fielden EM
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1079-81. PubMed ID: 3755711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical trials of radiosensitizers: what should we expect?
    Brown JM
    Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):425-9. PubMed ID: 6231272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ocular absorption and toxicity of a radiosensitizer and its effect on hypoxic cells.
    Rootman J; Josephy PD; Adomat H; Palcic B
    Arch Ophthalmol; 1982 Mar; 100(3):468-71. PubMed ID: 7199901
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reductive fragmentation of 2-nitroimidazoles in the presence of nitroreductases--glyoxal formation from misonidazole.
    Raleigh JA; Liu SF
    Biochem Pharmacol; 1983 Apr; 32(8):1444-6. PubMed ID: 6687998
    [No Abstract]   [Full Text] [Related]  

  • 52. Cellular uptake of misonidazole and analogues with acidic or basic functions.
    Dennis MF; Stratford MR; Wardman P; Watts ME
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jun; 47(6):629-43. PubMed ID: 3873433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined effects of misonidazole radiosensitization and hypoxic cell toxicity in mammalian cells.
    Michaels HB; Peterson EC; Ling CC; Epp ER
    Radiat Res; 1981 Nov; 88(2):354-68. PubMed ID: 7302141
    [No Abstract]   [Full Text] [Related]  

  • 54. Benznidazole: nitroreduction and inhibition of cytochrome P-450 in chemosensitization of tumour response to cytotoxic drugs.
    Workman P; Walton MI; Lee FY
    Biochem Pharmacol; 1986 Jan; 35(1):117-9. PubMed ID: 3940522
    [No Abstract]   [Full Text] [Related]  

  • 55. Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients.
    Moore JL; Paterson IC; Newman H; Venables S
    Br J Cancer; 1981 Oct; 44(4):592-6. PubMed ID: 7295516
    [No Abstract]   [Full Text] [Related]  

  • 56. Changes in misonidazole binding with hypoxic fraction in mouse tumors.
    Hirst DG; Hazlehurst JL; Brown JM
    Int J Radiat Oncol Biol Phys; 1985 Jul; 11(7):1349-55. PubMed ID: 4008291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of misonidazole on tumor cell radiation sensitivity and potentially lethal damage repair in vivo and in vitro.
    Sakamoto K; Aritake S
    Eur J Cancer Clin Oncol; 1981 Jul; 17(7):825-30. PubMed ID: 7199475
    [No Abstract]   [Full Text] [Related]  

  • 58. Enhancement of artificial lung metastases by misonidazole.
    Rockwell S; Nierenburg M; Irvin CG
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1395-8. PubMed ID: 6469763
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of the hypoxic radiosensitizers misonidazole and demethylmisonidazole after intraperitoneal administration in humans.
    Gianni L; Jenkins JF; Greene RF; Lichter AS; Myers CE; Collins JM
    Cancer Res; 1983 Feb; 43(2):913-6. PubMed ID: 6848201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The pharmacokinetics in mice and dogs of nitroimidazole radiosensitizers and chemosensitizers more lipophilic than misonidazole.
    White R; Workman P; Owen L
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):473-6. PubMed ID: 7107369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.